Emerging BioTalk
  • Home
  • About Us
  • Contact
  • Search
  • Menu

Covid-19 Impact on Bioprocessing: PART 2 Fears to Be Addressed due to Covid-19

October 22, 2020/in Uncategorized /by Multiple Authors

The views and opinions expressed in this blog / article are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Merck KGaA, Darmstadt, Germany and its Affiliates shall not be liable for any errors, omissions or delays in the information, or damage arising from its display or use. All information is provided on an as-is basis.

Introduction

We follow up our Part 1 discussion of the impact of Covid-19 on bioprocessing, based on our recent White Paper that is also included in our research, (see www.bioplanassociates.com/17th). We interviewed major biopharmaceutical industry senior bioprocessing decision-makers, and bioprocessing suppliers in the US and Europe. The impact on emerging biopharma companies as well as smaller suppliers may actually be a small silver-lining for some, during this global, horrific event.  The demand on the industry segment for capacity, support and services has trickled down from the largest suppliers to the mid-tier, and even smaller providers of equipment, services, diagnostics, reagents, devices and capacity. For those on the front lines of bioprocessing, our interviews report some of the key fears, and options for their resolution that may result in a future “new normal” for bioprocessing. Worsening shortage of single-use technologies and is a key fear that will require resolution. Already there are long wait times for many single-use supplies, and these will likely lengthen (for non-pandemic response-related projects).

Fig 2: Key Fears and Resolutions in Bioprocessing Post Covid-19

What came to the front include:

  • “Shortage of SUS & other supplies” inability to obtain needed SUS (75% of users)
  • “Prioritization will hurt.” [non-Covid-19 projects] prioritized activities pushing pandemic/ biodefense to front of the line.
  • Real Shortages: Prioritization combined with worsening shortages (order lead/wait times) resulting problems w/equipment and CMO services
  • Developers’ fears: shortages and prioritization – end-users need reassurance from their suppliers.

In the future, respondents, both biopharma company and suppliers, expect to see a different ‘new normal’.  Changes include collaborations among stake-holders are likely to increase. Today, as the world works through this crisis, collaborations are seen as indispensable.  This includes cross-company, cross-industry, with governments, and multi-nationally.  There is a clear sense that we are all in this together, and that the current situation may be well be defining our relationships in the future.  If any positive outcome results from this pandemic, it may be the recognition that working together is essential today, and this will likely carry out into the future.  Many also foresee practical benefits, including improved public perceptions of the (bio)pharmaceutical industry.

Pandemic-related Trends

Some pandemic-related changes or trends with long term, strategic implications include:

Pandemic Related Trends: Big Picture

  • Bioprocessing accelerating globally: By mid-May, more than 215 novel and repurposed Covid-19 therapies in the pipeline…investment, political interest
  • Outsourcing: Use of CMOs accelerating both for pandemic-related projects, and lower priority projects. 70% believe outsourcing will accelerate long-term.
  • Regionalization: More bioprocessing, more multi-site facilities internationally, more facilities to serve regional markets, including China; pandemic accelerating the trend toward supply chain and bioprocessing facilities’ diffusion worldwide.
  • Supply chain security/strengthening: Emphasis on secure supplies, backup sources. Transparency in supply chains; coordination among suppliers and customer.  Political and economic demand for supply chain security:  APIs, raw ingredients, materials, plastics

      …all being evaluated for in-shoring.

Conclusions

Even before the current Covid-19 pandemic all of these trends were evident.  Based on our current research, we found changes being undertaken resulting from the pandemic that are impacting near-term industry dynamics.  But the future-casting offered by industry executives presented some significant, long-term transformational changes that are likely to occur, as well.

  • “More Collaborations” 70% of Suppliers expect to work more collaboratively with:
    • Their customers
    • Vendors
    • Raw materials suppliers (including supply chain security and transparency)
  • “More R&D”
    • More investment

  • Author
  • Recent Posts
Eric Langer
Eric Langer
President and Managing Partner at BioPlan Associates, Inc.
Eric S. Langer is president and managing partner at BioPlan Associates, Inc., a biotechnology and life sciences marketing research and publishing firm established in Rockville, MD in 1989. He is editor of numerous studies, including “Biopharmaceutical Technology in China,” “Advances in Large-scale Biopharmaceutical Manufacturing,” and many other industry reports.
www.bioplanassociates.com
Eric Langer
Latest posts by Eric Langer (see all)
  • Hiring Challenges in Bioprocessing for Start-ups - May 13, 2020
  • Author
  • Recent Posts
Ronald Rader
Ronald Rader
Ronald A. Rader is the Senior Director, Technical Research, BioPlan Associates.He has 35+ years’ experience as a biotechnology and pharmaceutical, particularly biopharmaceutical, information specialist, analyst and publisher, and has been responsible for the Antiviral Agents Bulletin periodical; Federal Bio-Technology Transfer Directory; BIOPHARMA:Biopharmaceutical Products in the U.S. and European Market; and the Biosimilars/Biobetters Pipeline Directory
Ronald Rader
Latest posts by Ronald Rader (see all)
    • Author
    • Recent Posts
    Kamna Jhamb
    Dr. Kamna Jhamb is a life sciences and healthcare market researcher. With a PhD in Biotechnology/Microbiology, she has extensive experience working in several key industry segments, and has experience at the Lawrence Berkeley National Lab (LBNL), Berkeley, CA and elsewhere. Her expertise lies in primary and secondary research, and market analysis of healthcare and biopharma segments. She contributes to international publications and journals, and researches for in-depth reports, analyses and strategic White Papers.
    Latest posts by Kamna Jhamb (see all)
      +1
      Share this entry
      • Share on Facebook
      • Share on Twitter
      • Share on LinkedIn
      • Share by Mail
      http://emergingbiotalk.com/wp-content/uploads/2020/06/manufacturing002.jpg 630 1500 Multiple Authors http://emergingbiotalk.com/wp-content/uploads/2020/05/emergingbiotalk-header.png Multiple Authors2020-10-22 13:46:012020-10-26 12:02:23Covid-19 Impact on Bioprocessing: PART 2 Fears to Be Addressed due to Covid-19

      Biotech Resource Hub >>

      • SUBSCRIBE TO OUR BLOG
      • SUBMIT YOUR BLOG POST

      Latest News

      • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
      • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
      • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

      Categories

      • Bioprocessing
      • Biosafety Testing
      • End-to-End Solutions
      • Frontpage Article
      • Gene Therapy
      • Investigator's Brochure
      • News
      • Uncategorized
      • Vaccines
      • Viral Vectors
      • Webinar

      Archives

      • February 2023
      • January 2023
      • December 2022
      • November 2022
      • October 2022
      • September 2022
      • August 2022
      • July 2022
      • May 2022
      • April 2022
      • March 2022
      • February 2022
      • January 2022
      • November 2021
      • October 2021
      • September 2021
      • August 2021
      • July 2021
      • June 2021
      • May 2021
      • April 2021
      • March 2021
      • February 2021
      • January 2021
      • December 2020
      • November 2020
      • October 2020
      • September 2020
      • August 2020
      • July 2020
      • May 2020
      • April 2020
      • SUBSCRIBE TO OUR BLOG
      • SUBMIT YOUR BLOG POST

      Latest News

      • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
      • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
      • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

      Categories

      • Bioprocessing
      • Biosafety Testing
      • End-to-End Solutions
      • Frontpage Article
      • Gene Therapy
      • Investigator's Brochure
      • News
      • Uncategorized
      • Vaccines
      • Viral Vectors
      • Webinar

      Archives

      • February 2023
      • January 2023
      • December 2022
      • November 2022
      • October 2022
      • September 2022
      • August 2022
      • July 2022
      • May 2022
      • April 2022
      • March 2022
      • February 2022
      • January 2022
      • November 2021
      • October 2021
      • September 2021
      • August 2021
      • July 2021
      • June 2021
      • May 2021
      • April 2021
      • March 2021
      • February 2021
      • January 2021
      • December 2020
      • November 2020
      • October 2020
      • September 2020
      • August 2020
      • July 2020
      • May 2020
      • April 2020

      Tags

      applications bioprocessing biotech blazar Congratulations Content education Europe FDA Format gene therapy grant grants Investigator's Brochure molecule new NGS Pharmaceuticals program services symposia tags things Tone VAR2 viral assurance viral clearance virus virus detection winner

      Business Hours

      Our support Hotline is available 24 Hours a day: (555) 343 456 7891

      • Monday-Friday: 9am to 5pm
      • Saturday: 10am to 2pm
      • Sunday: Closed

      Latest News

      • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
      • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
      • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am
      • The Future of BiopharmaDecember 6, 2022 - 4:39 am
      • Last chance: 3rd Annual Startup Symposium – Day 3November 10, 2022 - 5:39 am
      • The Lack of Funding for Women Entrepreneurs Doesn’t Stop Them from Launching – But We Still Have a Long Way to Go – And We Can Help Each Other. Assurea is ROOTING FOR YOU!October 21, 2022 - 8:27 am

      Categories

      • Bioprocessing
      • Biosafety Testing
      • End-to-End Solutions
      • Frontpage Article
      • Gene Therapy
      • Investigator's Brochure
      • News
      • Uncategorized
      • Vaccines
      • Viral Vectors
      • Webinar
      • Author
      • Recent Posts
      Kamna Jhamb
      Dr. Kamna Jhamb is a life sciences and healthcare market researcher. With a PhD in Biotechnology/Microbiology, she has extensive experience working in several key industry segments, and has experience at the Lawrence Berkeley National Lab (LBNL), Berkeley, CA and elsewhere. Her expertise lies in primary and secondary research, and market analysis of healthcare and biopharma segments. She contributes to international publications and journals, and researches for in-depth reports, analyses and strategic White Papers.
      Latest posts by Kamna Jhamb (see all)
        +1
        © 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. | Privacy Policy | Cookie Settings
        Finding That Perfect Person for the Emerging Life Science Company Covid-19 Impact on Bioprocessing: PART 3 Long-term Changes Resulting from the...
        Scroll to top

        This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to allow. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Policy

        Accept All CookiesCookie Settings

        Cookie and Privacy Settings



        Cookie Preferences

        When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about how we use and share your data, please follow this link.
        Privacy Statement

        Necessary

        Always Active
        These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.

        Functional

        These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., pop-up notification choices).Changes will take effect once you reload the page.

        Targeting

        These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.

        Confirm My ChoicesAllow AllDisable All

        loading

        Please wait while you are redirected to the right page...

        Please share your location to continue.

        Check our help guide for more info.

        share your location